Blueprint Medicines Corp (NASDAQ:BPMC)

95.61
Delayed Data
As of Mar 05
 +3.60 / +3.91%
Today’s Change
43.29
Today|||52-Week Range
125.61
-14.75%
Year-to-Date

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Blueprint Medicines Corp have a median target of 120.00, with a high estimate of 152.00 and a low estimate of 81.00. The median estimate represents a +25.51% increase from the last price of 95.61.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in Blueprint Medicines Corp. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.75
Sales
$23.6M
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -14.52%
 
 
 
 
 
 
Growthannually -217.02%
 
 
 
 
 
 

Sales

Growthquarterly -30.75%
 
 
 
 
 
 
Growthannually -80.42%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.